Abdominal symptoms during Sjogren’s syndrome: a pilot study

Table 2 Association between a GSS and characteristics of pSS

	GSS ≤ 10 (n = 85)	GSS > 10 (n = 63)	p-value ^a
	n (%) or mean (sd)		p-value ^a
GSS	5.2 (2.8)	15.8 (3.5)	< 0.0001
ESSPRI score	16.4 (5.9)	20.1 (5.3)	0.0001
SSA negative status	28 (32.9%)	23 (63.5%)	0.0003
Articular involvement ^b	54 (63.5%)	52 (82.5%)	0.0112
Muscular involvement ^b	33 (38.8%)	34 (54.0%)	0.0672
Pulmonary involvement ^b	6 (7.1%)	10 (15.9%)	0.0877
Neurological involvement ^b	16 (18.8%)	18 (28.6%)	0.1633
Antecedent of gastroparesis	0 (0%)	9 (14.3%)	0.0003
Standard antalgics	21 (24.7%)	28 (44.4%)	0.0116
Neurotropic antalgics	11 (12.9%)	14 (22.2%)	0.1362
Digestive treatment	35 (41.2%)	37 (58.7%)	0.0346

GSS global symptom score, sd standard deviation, pSS primary Sjögren’s syndrome
^aFor quantitative variables in a normal distribution, the Student’s t-test was used to compare groups of two or more classes; for variables that do not follow a normal distribution, the Wilcoxon signed-rank test or the Kruskal-Wallis test was used to compare groups of two or more classes
^bas defined by the ESSDAI score

ISSN: 2523-3106